FDA Suspends Keytruda Combination Trials for Myeloma After Patient Deaths
multiple myeloma, News The U.S. Food and Drug Administration (FDA) has ordered Merck to suspend two Phase 3 and part of a Phase 1 clinical trials in which Keytruda (pembrolizumab) is tested in combination ... Read more